Projects per year
Abstract
Type 1 diabetes (T1D) is an autoimmune disease that selectively destroys insulin-producing β-cells in the pancreas. An unmet need in diabetes management, current therapy is focussed on transplantation. While the reprogramming of progenitor cells into functional insulin-producing β-cells has also been proposed this remains controversial and poorly understood. The challenge is determining why default transcriptional suppression is refractory to exocrine reactivation. After the death of a 13-year-old girl with established insulin-dependent T1D, pancreatic cells were harvested in an effort to restore and understand exocrine competence. The pancreas showed classic silencing of β-cell progenitor genes with barely detectable insulin (Ins) transcript. GSK126, a highly selective inhibitor of EZH2 methyltransferase activity influenced H3K27me3 chromatin content and transcriptional control resulting in the expression of core β-cell markers and ductal progenitor genes. GSK126 also reinstated Ins gene expression despite absolute β-cell destruction. These studies show the refractory nature of chromatin characterises exocrine suppression influencing β-cell plasticity. Additional regeneration studies are warranted to determine if the approach of this n-of-1 study generalises to a broader T1D population.
Original language | English |
---|---|
Article number | 248 |
Number of pages | 9 |
Journal | Signal Transduction and Targeted Therapy |
Volume | 7 |
Issue number | 1 |
DOIs | |
Publication status | Published - 22 Jul 2022 |
-
Human pancreatic ductal cell-driven beta-cell regeneration
El-Osta, S. (Primary Chief Investigator (PCI)), Cooper, M. (Chief Investigator (CI)), Al-Hasani, K. (Chief Investigator (CI)), Loudovaris, T. (Associate Investigator (AI)) & Khurana, I. (Associate Investigator (AI))
1/02/22 → 31/01/23
Project: Research
-
-
Identifying the epigenomic fingerprint of coronary heart disease in Chinese adults with type 2 diabetes
El-Osta, S. (Primary Chief Investigator (PCI)), Huang, Y. (Chief Investigator (CI)), Chan, J. C. N. (Chief Investigator (CI)), Thomas, M. (Chief Investigator (CI)), Cooper, M. (Chief Investigator (CI)) & Khurana, I. (Chief Investigator (CI))
1/01/16 → 31/12/20
Project: Research